Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B-Reference-Cited by-同舟云学术

Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B

Published:2016-06-21 Issue:1 Volume:89 Page:130-138
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Chuaypen Natthaya¹,Sriprapun Methee¹,Praianantathavorn Kesmanee¹,Payungporn Sunchai¹,Wisedopas Naruemon²,Poovorawan Yong³,Tangkijvanich Pisit¹

Affiliation:

1. Research Unit of Hepatitis and Liver Cancer; Chulalongkorn University; Bangkok Thailand

2. Department of Pathology; Chulalongkorn University; Bangkok Thailand

3. Center of Excellence in Clinical Virology; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand

Funder

International Research Integration

Chula Research Scholar

Ratchadaphiseksomphot Endowment Fund

The 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship

National Science and Technology Development Agency

Research Unit of Hepatitis and Liver Cancer and Center of Excellence in Clinical Virology, Chulalongkorn University

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference33 articles.

1. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group;Bedossa;Hepatology,1996

2. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome;Belloni;J Clin Invest,2012

3. Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B;Brunetto;Hepatology,2009

4. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response;Chan;Clin Gastroenterol Hepatol,2007

5. Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B;Chuaypen;Liver Int,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review;Journal of Viral Hepatitis;2024-08-16

2. Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation;European Journal of Gastroenterology & Hepatology;2024-07-22

3. Evaluation of reverse transcription-polymerase chain reaction and simultaneous amplification and testing for quantitative detection of serum hepatitis B virus RNA;Heliyon;2023-08

4. The role of HBV cccDNA in occult hepatitis B virus infection;Molecular and Cellular Biochemistry;2023-02-03

5. Network pharmacology and experimental validation to reveal the anti-hepatitis B virus pharmacological mechanism of Phyllanthus urinaria L.;Traditional Medicine Research;2023